Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CLYMClimb Bio, Inc.

Nasdaq · CIK 0001768446
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts253

Identity from submissions API

NameClimb Bio, Inc.
CIK0001768446
TickersCLYM
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN832273741
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone1-866-857-2596
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Eliem Therapeutics, Inc. (2019-02-19T05:00:00.000Z → 2024-09-20T04:00:00.000Z)
Business address
20 WILLIAM STREET
SUITE G50
WELLESLEY HILLS
MA
MA
Mailing address
20 WILLIAM STREET
SUITE G50
WELLESLEY HILLS
MA
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

326 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-09 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000257 005-92797 261537177 34 20210
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002706 005-92797 261526130 34 11693
2026-11-05 S-3ASR S-3ASR 0001193125-26-448619 333-299834 261524863 33 1333374 1 1
2026-11-05 10-Q 10-Q 0001193125-26-448567 001-40708 261524752 34 11956670 1 1
2026-11-05 8-K 8-K 2.02,7.01,9.01 0001193125-26-448556 001-40708 261524737 34 27807994 1 1
2026-10-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193805-26-001408 005-92797 261492595 34 16586
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003774 005-92797 261491639 34 10839
2026-10-26 8-K 8-K 7.01,8.01,9.01 0001193125-26-430997 001-40708 261483467 34 27171407 1 1
2026-10-23 8-K 8-K 7.01,8.01,9.01 0001193125-26-430681 001-40708 261483108 34 277512 1 1
2026-09-30 4 xslF345X06/form4-09302026_080936.xml 0001231919-26-001416 35334
2026-09-17 4 4 0001193125-26-394357 5557
2026-09-15 144 xsl144X01/primary_doc.xml 0001950047-26-009491 001-40708 261381111 33 4802
2026-09-03 8-K 8-K 7.01,9.01 0001193125-26-381060 001-40708 261356731 34 3153745 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001687078-26-000018 005-92797 261281023 34 7125
2026-08-14 8-K 8-K 8.01 0001193125-26-350596 001-40708 261276399 34 141066 1 1
2026-08-06 10-Q 10-Q 0001193125-26-336774 001-40708 261246068 34 10709313 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-336762 001-40708 261246024 34 346630 1 1
2026-07-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001452 005-92797 261161026 34 11226
2026-07-07 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000189 005-92797 261159795 34 24877
2026-07-01 4 xslF345X06/form4-07012026_090743.xml 0001231919-26-000722 18351
2026-07-01 4 4 0001193125-26-292640 6501
2026-07-01 3 3 0001193125-26-292617 19961
2026-07-01 8-K 8-K 5.02 0001193125-26-292567 001-40708 261145311 34 146196 1 1
2026-06-30 4 4 0001193125-26-291131 9656
2026-06-30 144 xsl144X01/primary_doc.xml 0001193125-26-291127 001-40708 261142174 33 4279
2026-06-12 8-K 8-K 1.01,8.01,9.01 0001193125-26-269567 001-40708 261087371 34 442637 1 1
2026-06-12 424B5 424B5 0001193125-26-269510 333-283166 261087082 33 457367
2026-06-11 8-K 8-K 8.01 0001193125-26-266688 001-40708 261081432 34 155906 1 1
2026-06-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001931 333-296346 261077894 33 1851
2026-06-09 424B3 424B3 0001193125-26-263813 333-296346 261076437 33 223546
2026-06-08 4 xslF345X06/form4-06082026_100640.xml 0001231919-26-000610 18332
2026-06-08 4 4 0001193125-26-262292 6466
2026-06-08 4 4 0001193125-26-262290 21180
2026-06-08 4 4 0001193125-26-262287 20770
2026-06-08 4 4 0001193125-26-262281 20826
2026-06-08 4 4 0001193125-26-262273 5484
2026-06-08 4 4 0001193125-26-262270 5514
2026-06-08 8-K 8-K 5.02,5.07,9.01 0001193125-26-261716 001-40708 261072658 34 368299 1 1
2026-06-05 CORRESP filename1.htm 0001193125-26-259490 5503
2026-06-05 8-K 8-K 8.01 0001193125-26-258372 001-40708 261066851 34 155179 1 1
2026-06-04 UPLOAD filename1.pdf 0000000000-26-005649 333-296346 147077
2026-05-29 S-3 S-3 0001193125-26-248243 333-296346 261044322 33 472259 1 1
2026-05-07 10-Q 10-Q 0001193125-26-210357 001-40708 26950888 34 9251210 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-210295 001-40708 26950800 34 287153 1 1
2026-05-05 8-K 8-K 7.01,9.01 0001193125-26-205079 001-40708 26940482 34 6214178 1 1
2026-05-04 D xslFormDX01/primary_doc.xml 06b 0001768446-26-000001 021-582793 26937688 33 18019
2026-04-29 4 xslF345X06/form4-04292026_100401.xml 0001231919-26-000429 18443
2026-04-29 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000123 005-92797 26918918 34 27438
2026-04-28 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-26-183711 001-40708 26903291 34 782965 1 1
2026-04-24 ARS ARS 0001193125-26-177320 001-40708 26894295 34 1628515
2026-04-24 DEFA14A DEFA14A 0001193125-26-177302 001-40708 26894188 34 115480
2026-04-24 DEF 14A DEF 14A 0001193125-26-177271 001-40708 26894092 34 2649026 1 1
2026-04-10 PRE 14A PRE 14A 0001193125-26-151243 001-40708 26854872 34 2540927 1 1
2026-04-03 8-K 8-K 5.02 0001193125-26-142114 001-40708 26838124 34 144138 1 1
2026-03-05 S-8 S-8 0001193125-26-092565 333-294029 26724195 33 188285 1 1
2026-03-05 10-K 10-K 0001193125-26-092546 001-40708 26724188 34 16579339 1 1
2026-03-05 8-K 8-K 2.02,9.01 0001193125-26-092520 001-40708 26724175 34 319955 1 1
2026-02-27 4 4 0001193125-26-082533 6814
2026-02-25 144 xsl144X01/primary_doc.xml 0001950047-26-001761 001-40708 26679074 33 6261
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001687078-26-000006 005-92797 26641160 34 6891
2026-02-17 4 4 0001193125-26-054568 6816
2026-02-12 144 xsl144X01/primary_doc.xml 0001950047-26-001212 001-40708 26626680 33 5413
2026-01-08 4 4 0001193125-26-007670 5564
2026-01-08 4 4 0001193125-26-007667 5589
2026-01-08 4 4 0001193125-26-007665 5535
2026-01-08 4 4 0001193125-26-007662 5587
2026-01-08 8-K 8-K 7.01,8.01,9.01 0001193125-26-006994 001-40708 26517342 34 203657 1 1
2026-01-07 4 xslF345X05/form4-01072026_090137.xml 0001231919-26-000018 21490
2025-12-31 8-K 8-K 8.01,9.01 0001193125-25-338318 001-40708 251617601 34 206935 1 1
2025-12-15 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001346824-25-000074 005-92797 251573035 34 36751
2025-12-15 4 xslF345X05/form4-12162025_121255.xml 0001231919-25-000616 28494
2025-12-11 8-K 8-K 1.01,3.02,9.01 0001193125-25-315108 001-40708 251563568 34 296467 1 1
2025-11-06 10-Q 10-Q 0001193125-25-268086 001-40708 251456144 34 10892505 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-268075 001-40708 251456130 34 356107 1 1
2025-10-17 8-K 8-K 8.01 0001193125-25-241951 001-40708 251398900 34 147268 1 1
2025-10-16 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-241629 005-92797 251398533 34 166168
2025-10-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-233582 005-92797 251380408 34 142714
2025-10-01 4 4 0001193125-25-227099 5536
2025-10-01 3 3 0001193125-25-227090 27761
2025-10-01 8-K 8-K 5.02,9.01 0001193125-25-227025 001-40708 251365642 34 240009 1 1
2025-09-29 8-K 8-K 7.01,8.01,9.01 0001193125-25-221756 001-40708 251352301 34 5663180 1 1
2025-09-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-088802 005-92797 251321920 34 20393
2025-08-12 10-Q 10-Q 0000950170-25-106916 001-40708 251204009 34 10676094 1 1
2025-08-12 8-K 8-K 2.02,9.01 0000950170-25-106913 001-40708 251204003 34 361255 1 1
2025-08-11 4 4 0000950170-25-106563 4904
2025-07-01 4 4 0000950170-25-092284 26645
2025-07-01 4 4 0000950170-25-092273 24395
2025-06-23 3 3 0000950170-25-088986 28253
2025-06-20 4 4 0000950170-25-088525 5577
2025-06-20 4 4 0000950170-25-088524 9152
2025-06-20 3 3 0000950170-25-088516 22011
2025-06-18 8-K 8-K 5.02 0001193125-25-142359 001-40708 251055120 34 152055 1 1
2025-06-05 4 xslF345X05/form4-06052025_080655.xml 0001415889-25-015766 17881
2025-06-05 4 4 0000950170-25-082335 5389
2025-06-05 4 4 0000950170-25-082324 5355
2025-06-05 4 4 0000950170-25-082323 22616
2025-06-05 4 4 0000950170-25-082322 5377
2025-06-05 4 4 0000950170-25-082321 22029
2025-06-05 4 4 0000950170-25-082320 5347
2025-06-05 8-K 8-K 5.07 0001193125-25-135864 001-40708 251027096 34 148110 1 1
2025-05-23 DEFA14A DEFA14A 0001193125-25-125879 001-40708 25982935 34 18482
2025-05-23 8-K 8-K 5.02,9.01 0001193125-25-125866 001-40708 25982736 34 222269 1 1
2025-05-14 10-Q 10-Q 0000950170-25-070902 001-40708 25942622 34 9886080 1 1
2025-05-14 8-K 8-K 2.02,9.01 0000950170-25-070901 001-40708 25942597 34 385081 1 1
2025-04-25 ARS ARS 0001193125-25-096726 001-40708 25873762 34 1805763
2025-04-25 DEFA14A DEFA14A 0001193125-25-096718 001-40708 25873714 34 546912
2025-04-25 DEF 14A DEF 14A 0001193125-25-096697 001-40708 25873654 34 1901878 1 1
2025-04-01 4 4 0000950170-25-048558 5394
2025-04-01 4 4 0000950170-25-048555 5404
2025-04-01 4 4 0000950170-25-048549 5370
2025-04-01 3 3 0000950170-25-048540 22402
2025-04-01 3 3 0000950170-25-048529 19141
2025-04-01 S-8 S-8 0001193125-25-070421 333-286303 25799729 33 248049
2025-04-01 8-K 8-K 5.02 0001193125-25-069668 001-40708 25796555 34 156322 1 1
2025-03-27 4 4 0000950170-25-046083 7060
2025-03-25 8-K 8-K 1.01,2.02,9.01 0001193125-25-062629 001-40708 25768967 34 524846 1 1
2025-03-25 424B5 424B5 0001193125-25-062602 333-283166 25768829 33 393224
2025-03-25 10-K 10-K 0000950170-25-044350 001-40708 25768207 34 24339560 1 1
2025-03-20 4 4 0000950170-25-042777 9615
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001373604-25-000016 005-92797 25619935 34 7024
2025-01-15 4 4 0000950170-25-005840 5574
2025-01-15 4 4 0000950170-25-005839 5575
2025-01-15 4 4 0000950170-25-005836 5589
2025-01-10 8-K 8-K 1.01,2.02,8.01 0001193125-25-004129 001-40708 25520530 34 165993 1 1
2025-01-03 4 4 0000950170-25-001176 7053
2024-12-20 4 4 0000950170-24-139052 9104
2024-11-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-11-22 16:30:00 9999999995-24-003560 333-283166 241491746 33 1858
2024-11-20 CORRESP filename1.htm 0001193125-24-262544 5250
2024-11-19 UPLOAD filename1.pdf 0000000000-24-012796 333-283166 40213
2024-11-14 SC 13G/A deeptrack-elym093024a1.htm 0001172661-24-004748 005-92797 241457778 34 103383
2024-11-12 4 4 0000950170-24-125717 7644
2024-11-12 3 3 0000950170-24-125701 18315
2024-11-12 S-3 S-3 0001193125-24-256056 333-283166 241449399 33 1262992
2024-11-12 8-K 8-K 2.02,8.01,9.01 0000950170-24-125336 001-40708 241447936 34 665002 1 1
2024-11-12 10-Q 10-Q 0000950170-24-125294 001-40708 241447711 34 10143059 1 1
2024-10-15 8-K 8-K 2.02,7.01,9.01 0001193125-24-237196 001-40708 241369233 34 239973 1 1
2024-10-02 8-K 8-K 5.03,8.01,9.01 0001193125-24-231167 001-40708 241347502 34 317786 1 1
2024-09-20 4 4 0000950170-24-108582 10449
2024-08-27 8-K 8-K 5.02,9.01 0001193125-24-207854 001-40708 241250082 34 291348 1 1
2024-08-26 4 4 0000950170-24-100633 7987
2024-08-26 3 3 0000950170-24-100631 21166
2024-08-26 8-K 8-K 5.02,9.01 0001193125-24-206655 001-40708 241237729 34 248981 1 1
2024-08-16 SC 13D/A SC 13D/A 0001193125-24-202149 005-92797 241217003 34 84840
2024-08-14 SC 13G/A AMENDMENT TO SCHEDULE 13G 0001999371-24-010145 005-92797 241207471 34 77347
2024-08-14 8-K 8-K 2.02,9.01 0000950170-24-096627 001-40708 241203947 34 368297 1 1
2024-08-14 10-Q 10-Q 0000950170-24-096626 001-40708 241203935 34 8002658 1 1
2024-07-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-23 16:00:00 9999999995-24-002249 333-280784 241136003 33 1789
2024-07-23 4 xslF345X05/form4-07232024_090751.xml 0001415889-24-019946 9055
2024-07-23 424B3 424B3 0001193125-24-182968 333-280784 241134830 33 235698
2024-07-19 CORRESP filename1.htm 0001193125-24-181621 5280
2024-07-19 4 xslF345X05/form4-07192024_030734.xml 0001415889-24-019814 6110
2024-07-18 UPLOAD filename1.pdf 0000000000-24-008186 333-280784 40175
2024-07-17 4 xslF345X05/form4-07172024_100719.xml 0001415889-24-019706 4638
2024-07-16 4 xslF345X05/form4-07162024_100734.xml 0001415889-24-019610 6111
2024-07-12 S-3 S-3 0001193125-24-178585 333-280784 241114671 33 376881
2024-07-11 4 xslF345X05/form4-07122024_120744.xml 0001415889-24-019504 7583
2024-07-09 4 xslF345X05/form4-07092024_080757.xml 0001415889-24-019433 4638
2024-07-03 4 xslF345X05/form4-07032024_060700.xml 0001415889-24-019147 8923
2024-07-02 D xslFormDX01/primary_doc.xml 06b 0001768446-24-000002 021-517684 241096246 33 11990
2024-07-02 D xslFormDX01/primary_doc.xml 06b 0001768446-24-000001 021-517682 241096212 33 11988
2024-07-02 SC 13G deeptrack-elym062524.htm 0001172661-24-002631 005-92797 241095005 34 103168
2024-07-01 4 xslF345X05/form4-07022024_010700.xml 0001415889-24-018708 26296
2024-07-01 SC 13D/A SC 13D/A 0001104659-24-077010 005-92797 241092731 34 97517
2024-06-28 4 xslF345X05/form4-06282024_100608.xml 0001415889-24-018483 15918
2024-06-28 4 xslF345X05/form4-06282024_100647.xml 0001415889-24-018481 6387
2024-06-28 4 xslF345X05/form4-06282024_090606.xml 0001415889-24-018469 5534
2024-06-28 4 xslF345X05/form4-06282024_090644.xml 0001415889-24-018467 5504
2024-06-28 4 xslF345X05/form4-06282024_090603.xml 0001415889-24-018463 5512
2024-06-28 4 xslF345X05/form4-06282024_090603.xml 0001415889-24-018461 5508
2024-06-27 4 4 0000950170-24-078688 7964
2024-06-27 4 4 0000950170-24-078685 7377
2024-06-27 3 3 0000950170-24-078682 21552
2024-06-27 3 3 0000950170-24-078681 22450
2024-06-27 8-K 8-K 1.01,2.01,3.02,5.02,7.01,8.01,9.01 0001193125-24-170599 001-40708 241079591 34 2176637 1 1
2024-06-26 8-K 8-K 5.07,8.01 0001193125-24-169077 001-40708 241073706 34 169575 1 1
2024-06-21 4 xslF345X05/form4-06212024_060656.xml 0001415889-24-017799 9305
2024-06-14 DEFA14A DEFA14A 0001193125-24-161704 001-40708 241045799 34 117237
2024-06-12 DEFA14A DEFA14A 0001193125-24-159996 001-40708 241038945 34 38659
2024-06-12 8-K 8-K 5.02,8.01,9.01 0001193125-24-159994 001-40708 241038936 34 281078 1 1
2024-06-06 SC 13D/A SC 13D/A 0001104659-24-069100 005-92797 241025261 34 96555
2024-06-04 ARS ARS 0001193125-24-153671 001-40708 241016114 34 3545709
2024-06-04 DEFM14A DEFM14A 0001193125-24-153666 001-40708 241016104 34 3605272
2024-05-17 PREM14A PREM14A 0001193125-24-141798 001-40708 24960453 34 3610511
2024-05-17 SC 13D/A SC 13D/A 0001104659-24-063024 005-92797 24959992 34 95335
2024-05-17 SC 13D/A SC 13D/A 0001193125-24-141701 005-92797 24959445 34 88961
2024-05-15 10-Q 10-Q 0000950170-24-059995 001-40708 24946969 34 6513076 1 1
2024-05-07 SC 13G SCHEDULE FILED TO REPORT ACQUISTION OF BENEFICIAL OWNERSHIP 0001999371-24-005736 005-92797 24923521 34 43754
2024-04-29 10-K/A 10-K/A 0001193125-24-122192 001-40708 24890513 34 639286 1 1
2024-04-12 SC 13D/A SC 13D/A 0001104659-24-046867 005-92797 24842775 34 124337
2024-04-11 DEFA14A DEFA14A 0001193125-24-092528 001-40708 24837174 34 3491478
2024-04-11 8-K 8-K 1.01,3.02,5.02,7.01,9.01 0001193125-24-092520 001-40708 24837159 34 3881645 1 1
2024-04-08 4 xslF345X05/form4-04082024_090450.xml 0001415889-24-010516 7452
2024-03-28 S-8 S-8 0001193125-24-080687 333-278328 24799508 33 75069
2024-03-28 10-K 10-K 0000950170-24-038023 001-40708 24798801 34 9443339 1 1
2024-03-20 4 xslF345X05/form4-03202024_080318.xml 0001415889-24-008754 6009
2024-03-19 8-K 8-K 8.01,9.01 0001193125-24-070333 001-40708 24760518 34 212300 1 1
2024-03-18 SC 13D/A SC 13D/A 0001104659-24-035606 005-92797 24759733 34 129179
2024-03-04 4 xslF345X05/form4-03042024_040348.xml 0001415889-24-006211 11709
2024-02-07 SC 13G/A elym13g020724.htm 0001616824-24-000027 005-92797 24603082 34 82256
2023-11-17 SC 13D/A SC 13D/A 0001104659-23-119537 005-92797 231419238 34 104913
2023-11-14 10-Q 10-Q 0000950170-23-063675 001-40708 231405657 34 8942903 1 1
2023-11-13 SC 13D/A SC 13D/A 0001193125-23-276197 005-92797 231400029 34 90696
2023-08-10 10-Q 10-Q 0000950170-23-041303 001-40708 231159323 34 9596631 1 1
2023-07-20 8-K 8-K 2.02,8.01,9.01 0001193125-23-190074 001-40708 231098050 34 172579 1 1
2023-05-22 4 OWNERSHIP DOCUMENT 0001104659-23-063233 15679
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031540 5470
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031535 5466
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031527 5462
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031518 6113
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031509 6388
2023-05-19 8-K 8-K 5.07 0001193125-23-149424 001-40708 23941055 34 158596 1 1
2023-05-11 8-K 8-K 2.02,7.01,9.01 0000950170-23-021244 001-40708 23911140 34 11380209 1 1
2023-05-11 10-Q 10-Q 0000950170-23-021186 001-40708 23910797 34 8635427 1 1
2023-04-10 SC 13D/A SC 13D/A 0001104659-23-043639 005-92797 23811706 34 94104
2023-04-06 ARS ARS 0000950170-23-012077 001-40708 23806358 34 895552
2023-04-06 DEFA14A DEFA14A 0000950170-23-012071 001-40708 23806274 34 1086062
2023-04-06 DEF 14A DEF 14A 0000950170-23-012064 001-40708 23806191 34 3803228
2023-03-21 3 FORM 3 SUBMISSION 0001209191-23-020159 11285
2023-03-16 8-K 8-K 5.02 0001193125-23-072646 001-40708 23739249 34 153533 1 1
2023-03-14 4 FORM 4 SUBMISSION 0001209191-23-018531 11897
2023-03-08 SC 13G/A SC13G/A 0001140361-23-010678 005-92797 23716073 34 112259
2023-03-06 S-8 S-8 0001193125-23-061530 333-270304 23709695 33 78845
2023-03-06 8-K 8-K 2.02,9.01 0000950170-23-006282 001-40708 23709625 34 567037 1 1
2023-03-06 10-K 10-K 0000950170-23-006279 001-40708 23709580 34 12371080 1 1
2023-02-14 SC 13G/A d9913774_13ga.htm 0000919574-23-001570 005-92797 23627100 34 121485
2023-02-14 8-K 8-K 2.02,2.05,5.02,8.01,9.01 0001193125-23-036503 001-40708 23621505 34 431970 1 1
2023-02-08 SC 13G/A NONE 0001567619-23-002085 005-92797 23599647 34 82608
2023-01-24 8-K 8-K 5.02 0001193125-23-014221 001-40708 23548395 34 149963 1 1
2022-12-20 8-K 8-K 5.02 0001193125-22-309122 001-40708 221474712 34 157792 1 1
2022-11-14 8-K 8-K 2.02,7.01,9.01 0000950170-22-024621 001-40708 221379653 34 3837386 1 1
2022-11-14 10-Q 10-Q 0000950170-22-024611 001-40708 221379579 34 10859513 1 1
2022-11-02 4 FORM 4 SUBMISSION 0001209191-22-055412 6348
2022-11-02 4 FORM 4 SUBMISSION 0001209191-22-055407 5671
2022-11-02 4 FORM 4 SUBMISSION 0001209191-22-055404 5710
2022-11-02 4 FORM 4 SUBMISSION 0001209191-22-055400 5669
2022-10-05 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-22-257937 001-40708 221294539 34 10788240 1 1
2022-09-22 SC 13G SC 13G 0001193125-22-249265 005-92797 221259982 34 126438
2022-08-15 8-K 8-K 2.02,9.01 0000950170-22-017192 001-40708 221162170 34 588740 1 1
2022-08-15 10-Q 10-Q 0000950170-22-017181 001-40708 221162085 34 10197753 1 1
2022-07-18 8-K 8-K 8.01 0001193125-22-196384 001-40708 221089881 34 162763 1 1
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033223 5438
2022-06-01 4 OWNERSHIP DOCUMENT 0001104659-22-067196 15714
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033220 5434
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033217 5293
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033214 6081
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033210 6296
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033206 5430
2022-05-24 8-K 8-K 5.07 0001193125-22-158523 001-40708 22956781 34 155476 1 1
2022-05-16 10-Q 10-Q 0000950170-22-009931 001-40708 22925334 34 9955072 1 1
2022-05-16 8-K 8-K 2.02,9.01 0000950170-22-009922 001-40708 22925297 34 526406 1 1
2022-05-04 SC 13G NONE 0001567619-22-009491 005-92797 22890460 34 82606
2022-04-25 8-K 8-K 8.01 0001193125-22-117771 001-40708 22850430 34 159652 1 1
2022-04-08 DEFA14A DEFA14A 0001193125-22-100376 001-40708 22817321 34 37651
2022-04-08 DEF 14A DEF 14A 0001193125-22-100357 001-40708 22817249 34 354833
2022-04-04 SC 13G/A d9434414_13g-a.htm 0000919574-22-002536 005-92797 22803647 34 119820
2022-03-29 8-K 8-K 7.01,9.01 0001193125-22-087428 001-40708 22777385 34 2189068 1 1
2022-03-07 S-8 S-8 0001193125-22-068087 333-263347 22718834 33 75734
2022-03-07 8-K 8-K 2.02,9.01 0000950170-22-003001 001-40708 22718115 34 561171 1 1
2022-03-07 10-K 10-K 0000950170-22-002998 001-40708 22717993 34 24223617 1 1
2022-02-14 SC 13G d9128051_13g.htm 0000919574-22-001460 005-92797 22628980 34 120385
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005659 5503
2022-01-31 8-K 8-K 5.02 0001193125-22-023502 001-40708 22575049 34 159397 1 1
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005647 5464
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005639 5520
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005630 5462
2022-01-18 8-K 8-K 2.02,8.01 0001193125-22-011359 001-40708 22535960 34 160734 1 1
2021-11-22 8-K 8-K 8.01 0001193125-21-336740 001-40708 211432487 34 148748 1 1
2021-11-08 8-K 8-K 2.02,7.01,9.01 0000950170-21-003457 001-40708 211387937 34 3294147 1 1
2021-11-08 10-Q 10-Q 0000950170-21-003448 001-40708 211387868 34 11562842 1 1
2021-09-14 8-K/A 8-K/A 2.02,9.01 0000950170-21-001795 001-40708 211251259 34 541426 1 1
2021-09-13 8-K 8-K 2.02,9.01 0000950170-21-001784 001-40708 211249659 34 329325 1 1
2021-09-13 10-Q 10-Q 0000950170-21-001783 001-40708 211249632 34 7247800 1 1
2021-08-23 SC 13D SC 13D 0001193125-21-253941 005-92797 211196767 34 144213
2021-08-19 SC 13D SC 13D 0001104659-21-107764 005-92797 211190425 34 122669
2021-08-16 4 OWNERSHIP DOCUMENT 0001104659-21-106405 42585
2021-08-16 4 FORM 4 SUBMISSION 0001209191-21-051627 17172
2021-08-12 8-K 8-K 5.03,9.01 0001193125-21-244913 001-40708 211168847 34 48843
2021-08-12 S-8 S-8 0001193125-21-244905 333-258771 211168808 33 96360
2021-08-11 4 OWNERSHIP DOCUMENT 0001104659-21-103596 15543
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050959 5408
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050953 5434
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050944 5412
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050934 6272
2021-08-11 424B4 424B4 0001193125-21-243518 333-257980 211164441 33 5696757
2021-08-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-08-09 16:00:00 9999999995-21-003109 333-257980 211158259 33 1707
2021-08-09 S-1MEF S-1MEF 0001193125-21-240909 333-258661 211158181 33 53155
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050513 15655
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050483 9945
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050481 9809
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050479 7217
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050477 7199
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050475 7189
2021-08-09 3 OWNERSHIP DOCUMENT 0001104659-21-102320 24855
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050473 7215
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050470 9983
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050467 10021
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050465 10671
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050463 9982
2021-08-09 S-1/A S-1/A 0001193125-21-240313 333-257980 211156101 33 80915
2021-08-09 CORRESP filename1.htm 0001193125-21-240310 11622
2021-08-09 CORRESP filename1.htm 0001193125-21-240308 9002
2021-08-09 FWP FWP 0001193125-21-239831 333-257980 211154539 34 54912
2021-08-09 S-1/A S-1/A 0001193125-21-239810 333-257980 211154499 33 5778896
2021-08-05 CERT 8A_cert_ELYM.pdf 0001354457-21-000906 001-40708 211149169 34 748243
2021-08-05 CORRESP filename1.htm 0001193125-21-237632 9273
2021-08-04 CORRESP filename1.htm 0001193125-21-235944 11752
2021-08-04 CORRESP filename1.htm 0001193125-21-235938 8965
2021-08-03 CORRESP filename1.htm 0001193125-21-235072 15290
2021-08-03 8-A12B 8-A12B 0001193125-21-235064 001-40708 211140657 34 14322
2021-08-03 S-1/A S-1/A 0001193125-21-234890 333-257980 211139577 33 5769552
2021-08-02 UPLOAD filename1.pdf 0000000000-21-009461 42548
2021-08-02 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001193125-21-232117 333-257980 211134662 33 7161736
2021-07-28 CORRESP filename1.htm 0001193125-21-227757 82329
2021-07-16 S-1 S-1 0001193125-21-217529 333-257980 211096087 33 6887042
2021-07-12 DRSLTR filename1.htm 0000950123-21-008688 26609
2021-07-12 DRS/A filename1.htm 0000950123-21-008630 377-04848 211083882 33 5716088
2021-07-06 UPLOAD filename1.pdf 0000000000-21-008325 49523
2021-06-21 DRSLTR filename1.htm 0000950123-21-008071 42518
2021-06-21 DRS/A filename1.htm 0000950123-21-008037 377-04848 211031619 33 5739514
2021-06-09 UPLOAD filename1.pdf 0000000000-21-007108 57853
2021-05-28 D xslFormDX01/primary_doc.xml 06b 0001768446-21-000001 021-401012 21974796 33 13573
2021-05-12 DRS filename1.htm 0000950123-21-006065 377-04848 21915800 33 5110283
2020-11-03 D xslFormDX01/primary_doc.xml 06b 0001768446-20-000003 021-379616 201284459 33 10418
2019-10-23 D xslFormDX01/primary_doc.xml 06b 0001768446-19-000003 021-351683 191163165 33 8220
2019-10-23 D/A xslFormDX01/primary_doc.xml 06b 0001768446-19-000002 021-333123 191163142 33 8319
2019-02-19 D xslFormDX01/primary_doc.xml 06b 0001567619-19-004873 021-333123 19615718 33 8311

Latest XBRL company facts

One latest value per concept from companyfacts (253 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 58.74M 2026-10-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
dei EntityPublicFloat Entity Public Float USD 44.80M 2025-06-30 2025 FY 10-K 2026-03-05 0001193125-26-092546
ecd TrdArrSecuritiesAggAvailAmt TrdArrSecuritiesAggAvailAmt shares 100,000 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336774
ffd NetFeeAmt NetFeeAmt USD 0 2026-11-03 S-3ASR 2026-11-05 0001193125-26-448619
ffd TtlFeeAmt TtlFeeAmt USD 0 2026-11-03 S-3ASR 2026-11-05 0001193125-26-448619
ffd TtlOfferingAmt TtlOfferingAmt USD 0 2026-11-03 S-3ASR 2026-11-05 0001193125-26-448619
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-03 S-3ASR 2026-11-05 0001193125-26-448619
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-03 S-3ASR 2026-11-05 0001193125-26-448619
us-gaap AccountsPayableAndAccruedLiabilitiesFairValueDisclosure Accounts Payable and Accrued Liabilities, Fair Value Disclosure USD 32,000 2021-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003448
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 3.04M 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125294
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 21,000 2022-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017181
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 6.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 6.10M 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 2.90M 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 675,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -528,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 560.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD -1.50M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-07 0000950170-22-002998
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.04M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 5.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AssetAcquisitionConsiderationTransferredTransactionCost AssetAcquisitionConsiderationTransferredTransactionCost USD 5.85M 2024-01-01 2024-06-27 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap Assets Assets USD 236.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AssetsCurrent Assets, Current USD 210.15M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 197.00M 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap AssetsNoncurrent Assets, Noncurrent USD 2.82M 2021-06-30 2021 Q2 10-Q 2021-09-13 0000950170-21-001783
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 165.69M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 22.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 52.75M 2024-01-01 2024-06-27 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable Business Combination, Consideration Transferred, Equity Interests Issued and Issuable USD 41.87M 2024-01-01 2024-06-27 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 16.74M 2021-12-31 2021 FY 10-K 2022-03-07 0000950170-22-002998
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 1.20M 2024-06-27 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets USD 54.72M 2024-06-27 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 1.86M 2024-06-27 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities USD 1.97M 2024-06-27 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 1.60M 2024-06-27 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other USD 192,000 2024-06-27 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 52.75M 2024-06-27 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets USD 9.16M 2021-12-31 2021 FY 10-K 2022-03-07 0000950170-22-002998
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 225,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap Cash Cash USD 99.48M 2021-06-30 2021 Q2 10-Q 2021-09-13 0000950170-21-001783
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 39.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 160.70M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 39.87M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 4.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2020-12-31 2021 FY 10-K 2022-03-07 0000950170-22-002998
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 250.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 57.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 57.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap CommonStockValue Common Stock, Value, Issued USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -42.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -13.60M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009931
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 152.80M 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 166.05M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent Debt Securities, Available-for-sale, Amortized Cost, Noncurrent USD 22.37M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 18.59M 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038023
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 27.99M 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336774
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 952,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-059995
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 91,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 285,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 4.45M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 39.46M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.39M 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 91,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 28.20M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 37,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 1.10M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses USD 334,000 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 332,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.40M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 39.37M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 106,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD -15,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 100,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 200,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 266,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.56 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.5 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009931
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.56 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 1.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 588,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 19.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 14.30M 2021-12-31 2021 FY 10-K 2022-03-07 0000950170-22-002998
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-210357
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -24,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD 248,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021186
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 1.25M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 17.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 11.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038023
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 237,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -12.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD -1,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -228,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 83,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 2,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 403,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap IncomeTaxReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount USD 123,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 2.04M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 1.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -241,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 219,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD -608,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap InterestIncomeOperating Interest Income, Operating USD 8.13M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap InterestReceivable Interest Receivable USD 1.37M 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 5.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap Investments Investments USD 0 2020-12-31 2021 FY 10-K 2022-03-07 0000950170-22-002998
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 100,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-059995
us-gaap LeaseCost Lease, Cost USD 259,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 591,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 293,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 15,000 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 172,000 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 298,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 254,000 2023-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-041303
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 50,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 200,000 2023-07-31 2023 Q3 10-Q 2023-11-14 0000950170-23-063675
us-gaap Liabilities Liabilities USD 8.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 236.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap LiabilitiesCurrent Liabilities, Current USD 7.91M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 551,000 2020-12-31 2021 FY 10-K 2022-03-07 0000950170-22-002998
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 165.69M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 22.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -963,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 104.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -63.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -36.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 36.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -41.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -45.24M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 5.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap NumberOfOperatingSegments Number of Operating Segments Segments 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap NumberOfReportableSegments Number of Reportable Segments Segments 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap OperatingExpenses Operating Expenses USD 47.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -47.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap OperatingLeaseCost Operating Lease, Cost USD 250,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 279,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 541,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 463,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 605,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap OperatingLeasePayments Operating Lease, Payments USD 256,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 994,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 300,000 2026-05-01 2026-05-31 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals USD 600,000 2021-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003448
us-gaap OperatingLeasesIncomeStatementSubleaseRevenue Operating Leases, Income Statement, Sublease Revenue USD 33,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-059995
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.085 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 389,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap OtherAssets Other Assets USD 114,000 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 263,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 31,000 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 615,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024611
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 8.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap OtherOperatingIncome Other Operating Income USD 5.61M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125294
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 900,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021186
us-gaap OtherRestructuringCosts Other Restructuring Costs USD 23,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063675
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap PaymentsForRestructuring Payments for Restructuring USD 3.33M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 86,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 201,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-07 0000950170-22-002998
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 164.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 4.64M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 622,000 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 83.14M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024611
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 103.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 101.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -41.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 200,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017181
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 30.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 9.16M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-07 0000950170-22-002998
us-gaap RestrictedCash Restricted Cash USD 143,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 39.87M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 18.90M 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038023
us-gaap RestructuringAndRelatedCostIncurredCost Restructuring and Related Cost, Incurred Cost USD 2.25M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap RestructuringCharges Restructuring Charges USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-059995
us-gaap RestructuringCosts Restructuring Costs USD 3.36M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 200,000 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-041303
us-gaap RestructuringReserve Restructuring Reserve USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044350
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -331.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 1.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.10M 2026-05-01 2026-05-31 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 21,750 2018-01-01 2018-12-31 2022 Q3 10-Q 2022-11-14 0000950170-22-024611
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.97 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.08 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.05 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.047 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.04 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 16.19M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.97 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 6.40M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 820,629 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 6.44 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-13 0000950170-21-001783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 63.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 8.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.89 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 63.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 8.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 3.89 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 4.53 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 6.34 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 228.05M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 389,643 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 152.76M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 79,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 83.14M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006279
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2020-04-01 2020-06-30 2021 Q2 10-Q 2021-09-13 0000950170-21-001783
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.50M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap SubleaseIncome Sublease Income USD 11,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 2.02M 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038023
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-07 0000950170-22-002998
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 152.76M 2021-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017181
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 147.10M 2021-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017181
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2021-12-31 2021 FY 10-K 2022-03-07 0000950170-22-002998
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 15.35M 2021-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017181
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 15.35M 2021-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017181
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 15.35M 2021-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017181
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 263,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-070902
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 10.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap VariableLeaseCost Variable Lease, Cost USD 9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092546
us-gaap VariableLeasePayment Variable Lease, Payment USD 7,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009931
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 74.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 26.24M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009931
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 74.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448567

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →